Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.400
-0.040 (-2.78%)
May 14, 2025, 4:00 PM - Market closed
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $2.95 million as of May 14, 2025. Its market cap has decreased by -32.14% in one year.
Market Cap
2.95M
Enterprise Value
2.15M
1-Year Change
-32.14%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $2.95M, a decrease of -92.83%. That is a compound annual growth rate of -54.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 3.04M | -22.64% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |